论文部分内容阅读
目的探讨甲状腺微小癌(thyroid micocarcinoma,TMC)诊治经验。方法回顾性分析新疆医科大学第一附属医院在2002年1月-2011年12月收治的TMC患者的临床病理资料。结果 2007-2011年TMC检出率(4.9%)明显高于2002-2006年(1.0%),TMC组年龄≤45岁占53.24%(41/77),针吸细胞学检查阳性率17.64%(3/17),术中快速病理检查阳性率70.58%(12/17),淋巴结转移率55.76%(34/61),与同期甲状腺癌(直径>1cm)组相比,差异均有统计学意义。结论从免疫学角度研究TMC发病机制,提高TMC的诊治水平。
Objective To investigate the diagnosis and treatment of thyroid micocarcinoma (TMC). Methods The clinical and pathological data of patients with TMC admitted to the First Affiliated Hospital of Xinjiang Medical University from January 2002 to December 2011 were retrospectively analyzed. Results The detection rate of TMC in 2007-2011 was 4.9%, significantly higher than that in 2002-2006 (1.0%). The positive rate of needle aspiration cytology in TMC group was 53.24% (41/77), and the positive rate of needle aspiration cytology was 17.64% 3/17). The positive rate of intraoperative rapid pathological examination was 70.58% (12/17) and lymph node metastasis rate was 55.76% (34/61), which was significantly different from that of thyroid cancer (diameter> 1cm) in the same period . Conclusion From the perspective of immunology TMC pathogenesis, improve the diagnosis and treatment of TMC.